Month: July 2014

The Nagoya Protocol – Convention on Biological Diversity

A new international treaty named the “Nagoya Protocol” will be giving some relief to India and other developing countries. The Nagoya Protocol on Access to Genetic Resources with the objective of ensuring access of genetic resources to the signatory countries and ensuring fair and equitable sharing of benefit to the local community and signatory country … Continue reading The Nagoya Protocol – Convention on Biological Diversity

Read more »

Indian Patent office rejects Patent claim over Abraxane

In a major setback, the Indian Patent Office denied a patent to an anti-cancer drug Abraxane manufactured by US-Based Abraxis BioSciences. Here we will discuss the decision given by IPO at the backdrop of the arguments advanced by the respective parties. The copy of the decision made by the Controller General of Patents can be … Continue reading Indian Patent office rejects Patent claim over Abraxane

Read more »

Tesla Motors Decide to Open Source their Patents

On June 12th, 2014, Elon Musk, CEO and Chief Product Architect of electric car company Tesla Motors announced that Tesla Motors will let other companies use its inventions under an open-source inspired agenda at the company. This is how Elon Musk put it in his blog post- “Tesla will not initiate patent lawsuits against anyone … Continue reading Tesla Motors Decide to Open Source their Patents

Read more »

Odisha Court Admitted Case Against Aamir Khan Production’s Proposed ‘Satyamev Jayate’ Use as Trademark

As per the sources, the court in the Odisha capital, Bhuvaneshwar has admitted a petition challenging Aamir Khan Production’s plans to use ‘Satyamev Jayate’, the national motto of India, as a business brand under which it is proposed to sell everything from kitchen utensils to footwear. A city-based journalist and social activist, Dr. Subash Mohapatra … Continue reading Odisha Court Admitted Case Against Aamir Khan Production’s Proposed ‘Satyamev Jayate’ Use as Trademark

Read more »